Group One Trading
BHVN

Group One Trading’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Group One Trading’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-35,200
Closed -$5.32M – 8576
2022
Q3 		$5.32M Buy
35,200
+21,700
+161% +$3.22M 0.01% 1120
2022
Q2 		$1.97M Sell
13,500
-14,700
-52% -$1.88M ﹤0.01% 2080
2022
Q1 		$3.34M Buy
28,200
+9,000
+47% +$1.12M ﹤0.01% 1883
2021
Q4 		$2.65M Buy
19,200
+9,200
+92% +$1.17M ﹤0.01% 2299
2021
Q3 		$1.39M Buy
10,000
+5,400
+117% +$674K ﹤0.01% 3041
2021
Q2 		$447K Sell
4,600
-19,800
-81% -$1.61M ﹤0.01% 4334
2021
Q1 		$1.67M Sell
24,400
-52,800
-68% -$4.27M ﹤0.01% 2664
2020
Q4 		$6.62M Buy
77,200
+6,900
+10% +$585K 0.01% 1088
2020
Q3 		$4.57M Buy
70,300
+42,700
+155% +$2.8M 0.01% 982
2020
Q2 		$2.02M Sell
27,600
-12,600
-31% -$671K 0.01% 1466
2020
Q1 		$1.37M Sell
40,200
-400
-1% -$18.3K 0.01% 1288
2019
Q4 		$2.21M Sell
40,600
-112,900
-74% -$5.59M 0.02% 1215
2019
Q3 		$6.4M Sell
153,500
-97,200
-39% -$4.11M 0.05% 452
2019
Q2 		$11M Buy
250,700
+188,300
+302% +$10.6M 0.1% 214
2019
Q1 		$3.21M Buy
62,400
+18,600
+42% +$804K 0.04% 649
2018
Q4 		$1.62M Buy
43,800
+27,800
+174% +$1M 0.01% 1166
2018
Q3 		$601K Sell
16,000
-6,100
-28% -$224K ﹤0.01% 2140
2018
Q2 		$873K Sell
22,100
-73,500
-77% -$2.33M 0.01% 1847
2018
Q1 		$2.46M Buy
+95,600
New +$2.86M 0.02% 861

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Group One Trading's BHVN Position: Q3 2022 in Review

Group One Trading sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 3,881 shares — an estimated $575K sold.

Group One Trading first reported a position in BHVN in Q1 2018 and held it in 12 quarters. The position peaked at $4.5M in Q2 2019. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

  • Group One Trading reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
  • Group One Trading sold 3,881 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $575K.
  • Group One Trading first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2018 and held it in 12 quarters.
  • Group One Trading's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $4.5M in Q2 2019.
  • 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Group One Trading's 13F filing for Q3 2022, filed 9 Nov 2022.